PEG‐coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT‐6 Mouse Mammary Tumours

Journal of Pharmacy and Pharmacology

Volumn 47, Issue 5, 1995, Pages 382-387

  ALLEMANN, ERIC ^a   BRASSEUR, NICOLE ^a   BENREZZAK, OUHIDA ^a   ROUSSEAU, JACQUES ^a   KUDREVICH, SVETLANA V ^a   BOYLE, ROSS W ^a   LEROUX, JEAN‐CHRISTOPHE ^a,b   GURNY, ROBERT ^a,b   VAN LIER, JOHAN E ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREMOPHOR; MACROGOL; NANOPARTICLE; PHTHALOCYANINE ZINC; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; DRUG UPTAKE; FLUORESCENCE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LIVER METABOLISM; MALE; MOUSE; MUSCLE; NONHUMAN; PHARMACEUTICS; PHOTODYNAMIC THERAPY; RETICULOENDOTHELIAL SYSTEM; SKIN;

ANIMAL; COLLOIDS; DELAYED-ACTION PREPARATIONS; EMULSIONS; GLYCEROL; INDOLES; INJECTIONS, INTRAVENOUS; LACTATES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICROSPHERES; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; POLYMERS; RADIATION-SENSITIZING AGENTS; SOLVENTS; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0029070158     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1995.tb05815.x     Document Type: Article

References (34)

1. Preparation of aqueous polymeric nanodispersions by a reversible salting‐out process, influence of process parameters on particle size
2. Drug loaded nanoparticles—preparation methods and drug targeting issues
3. Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting‐out process: purification of an injectable dosage form
4. In vitro sustained release properties of drug loaded poly(d,l‐lactic acid) nanoparticles produced by a salting‐out procedure
5. Unusual serum lipoprotein abnormality induced by the vehicle of miconazole
6. Polyfluoroarenes. Part XIV. Synthesis of halogenophthalocyanines
7. Adsorption of hematoporphyrin onto poly‐alkyl‐cyanoacrylate nanoparticles: carrier capacity and drug release
8. Synthesis and photodynamic activities of silicon 2,3‐naphthalocyanine derivatives
9. The determination of polyethylene glycol in gamma globulin solutions
10. Microspheres for targeting drugs to specific body sites
11. Studies on in‐vitro uptake by Kupffer cells and the in‐vivo biodistribution of a range of novel polymeric colloids.
12. Suspected anaphylactic reaction to Cremophor EL.
13. The use of liposomes, emulsions or inclusion complexes may potentiate in vivo effects of SnET2
14. Delivery of the tumour photosensitizer zinc(II)‐phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo
15. How does photodynamic therapy work? Photochem
16. Experience with the liposomal delivery of the photosensitizer isoBoSiNc
17. Targeting of colloidal particles to the bone marrow
18. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymerpoloxamine 908
19. Preferential delivery of liposome‐incorporated porphyrins to neoplastic cells in tumour‐bearing rats
20. Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy
21. Internalization of poly(d,l‐lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles
22. Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908
23. Liposome‐ or LDL‐administered Zn(II)‐phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency
24. Characteristics of serially transplanted mouse mammary tumor and its tissueculture‐adapted derivative
25. Phthalocyanines as photodynamic sensitizers
26. A dose response analysis of purpurin derivatives used as photosensitizers for the photodynamic treatment of transplantable FANFT induced urothelial tumors
27. CGP 55 847, liposome‐delivered zinc(II)‐phthalocyanine as a phototherapeutic agent for tumors
28. Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats
29. 14C‐poly(methyl methacrylate) nanoparticles
30. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating surfactants
31. Phthalocyanines as sensitizers for the photodynamic therapy of cancer
32. The alteration of plasma lipoproteins by Cremophor EL
33. Mechanisms of tumor necrosis induced by photodynamic therapy